Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

PENUMBRA, INC.

United States·US-MF-000008514

Last updated September 17, 2026

Information

Country
United States
Address
One Penumbra Place, Alameda, United States
LinkedIn
—
Facebook
—
Phone
—
PRRC Contact
Mary Rose
EUDAMED SRN
US-MF-000008514
FDA FEI Number
3013758550
DUNS Number
191077671

Catalogue (1506)

Page 18 of 31
DeviceModel / ReferenceRegistriesClassStatus
Penumbra Coil 400 4006U0303
FDA UDI
Class IIActive
ACCESS25 Delivery Microcatheter PXAC045-A
FDA UDI
Class IIActive
Ace 5MAXACE068L125
FDA UDI
Class IIActive
Smart Coil 400SMTHXSFT0103
FDA UDI
Class IIActive
Penumbra System PSC054-B
FDA UDI
Class IIActive
Ace 5MAXACE068
FDA UDI
Class IIActive
Benchmark BMK6F95MBER120
FDA UDI
Class IIActive
Penumbra Coil 400 4006U0310
FDA UDI
Class IIActive
Red 43 RED43HFKIT153-A
FDA UDI
Class IIActive
Penumbra Coil 400 4006C0404-A
FDA UDI
Class IIActive
RUBY Coil RBY2C4060-B
FDA UDI
Class IIActive
Neuron PNML6F088904R
FDA UDI
Class IIActive
Ruby XL Coil System RBYPCXL15-A
FDA UDI
Class IIActive
Penumbra System PSC041
FDA UDI
Class IIActive
Neuron PNMD8F088904
FDA UDI
Class IIActive
Neuron PND6F10512M
FDA UDI
Class IIActive
Benchmark BMK6F95MSIM120-A
FDA UDI
Class IIActive
Indigo System LITNG8XTORQ115-A
FDA UDI
Class IIActive
Neuron PNML6F0881004M-R
FDA UDI
Class IIActive
Smart Coil 400SMTHXSFT0308
FDA UDI
Class IIActive
Lantern Delivery Catheter PXSLIMLAN150T45
FDA UDI
Class IIActive
Swift Coil System 400SWCCL512-A
FDA UDI
Class IIActive
Penumbra Coil 400 4004C0930-A
FDA UDI
Class IIActive
Penumbra System PAP110
FDA UDI
Class IIActive
Artemis AP28-A
FDA UDI
Class IIActive
LP Coil System RBYLP0630
FDA UDI
Class IIActive
Penumbra Coil 400 4004C2245
FDA UDI
Class IIActive
Penumbra Coil 400 4004C0615
FDA UDI
Class IIActive
Indigo System CAT12XTORQ100KIT
FDA UDI
Class IIActive
Swift Coil System 400SWPC20-A
FDA UDI
Class IIActive
Smart Coil 400SMTSTD0720
FDA UDI
Class IIActive
Penumbra Coil 400 4004C0925
FDA UDI
Class IIActive
Indigo System LITNGBT7XTQ130-A
FDA UDI
Class IIActive
Indigo System CAT8XTORQ115-B
FDA UDI
Class IIActive
Smart Coil 400SMTHXSFT0510
FDA UDI
Class IIActive
Penumbra Coil 400 4006C0408
FDA UDI
Class IIActive
Penumbra Coil 400 4002C0510
FDA UDI
Class IIActive
LP Coil System RBYLP0430-B
FDA UDI
Class IIActive
Indigo System CAT8STR85KIT-B
FDA UDI
Class IIActive
Smart Coil 400SMTXSFT2H04
FDA UDI
Class IIActive
RUBY Coil RBY6C0315-B
FDA UDI
Class IIActive
Neuron PNS5F130SIM
FDA UDI
Class IIActive
RUBY Coil RBY4C0305-A
FDA UDI
Class IIActive
Penumbra Coil 400 4002C0512
FDA UDI
Class IIActive
Smart Coil 400SMTSTD0306
FDA UDI
Class IIActive
Penumbra Coil 400 400PAC15
FDA UDI
Class IIActive
RUBY Coil RBY4C1240-B
FDA UDI
Class IIActive
Penumbra Coil 400 4002C1450-A
FDA UDI
Class IIActive
RUBY Coil RBY4C2060-B
FDA UDI
Class IIActive
Smart Coil 400SMTSTD0820
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (10)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Dec 15, 2020Z-0848-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Dec 15, 2020Z-0851-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Dec 15, 2020Z-0850-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Dec 15, 2020Z-0849-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Jun 9, 2017Z-2702-2017—terminated

Penumbra has identified an issue in these four lots involving a raw material component of the delivery wire. This issue could result in breakage of the delivery wire, which could potentially lead to serious patient injury or death.

Mar 4, 2011Z-1906-2011—terminated

The diameter of a component of the device is out of tolerance specification; the Delivery Pusher pull wire which secures the coil in place can prolapse and allow premature detachment of the coil.

Oct 25, 2010Z-0428-2011—terminated

Reperfusion catheter may fail at the mid-shaft joint and may break off. If the segment cannot be removed, it may result in blocked blood flow, requiring emergency medical treatment.

Sep 22, 2009Z-0001-2010—terminated

Failure-- product can kink or ovalize, which may result in difficulty in catheter advancement or delivery of other devices and damage to catheter, which could lead to patient injury or death as a result of portions being retained in the patient.

Jul 2, 2009Z-2049-2009—terminated

Leakage-- Due to a manufacturing error, some products may have a fold in the innermost layer, causing disruption in the layering process and may result in blow holds or exposed wire braids, which may result in further damage.

Jul 1, 2009Z-2313-2009—terminated

Misbranding--Some products may be identified with the wrong ID band content 'Neuron 6F 070' instead of 'Neuron 6F delivery'

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • Penumbra Inc. Roseville, CA · US FEI 3016591327